A Novel Anti-HER2 Antibody-Drug Conjugate XMT-1522 for HER2-Positive Breast and Gastric Cancers Resistant to Trastuzumab Emtansine

Vadim Le Joncour, Ana Martins, Maija Puhka, Jorma Isola, Marko Salmikangas, Pirjo Laakkonen, Heikki Joensuu, Mark Barok

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalMolecular Cancer Therapeutics
Volume18
Issue number10
Pages (from-to)1721-1730
Number of pages10
ISSN1535-7163
DOIs
Publication statusPublished - Oct 2019
MoE publication typeA1 Journal article-refereed

Fields of Science

  • INHIBITION
  • PLUS
  • HER2
  • 3122 Cancers

Cite this